Clinical Trial Update: Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 trial of biweekly FOLFIRI in advanced gastric cancer after failure of taxane, fluoropyrimidine, and cisplatin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• FOLFIRI (irinotecan, leucovorin, 5-fluorouracil)

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED